Table: Nippon Shinyaku -Q1 group results (IFRS)
Aug 9 (Reuters)-
Nippon Shinyaku Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2022 Jun 30, 2021 Mar 31, 2023
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 35.62 40.97 134.00
(-13.1 pct) (-2.5 pct)
Operating 10.28 16.56 27.00
(-37.9 pct) (-18.1 pct)
Pretax 10.51 16.77 27.50
(-37.3 pct) (-17.4 pct)
Net 8.25 12.59 21.50
(-34.5 pct) (-14.0 pct)
EPS Basic 122.48 yen 186.91 yen 319.21 yen
Ann Div 110.00 yen 112.00 yen
-Q2 Div 51.00 yen 56.00 yen
-Q4 Div 59.00 yen 56.00 yen
NOTE - Nippon Shinyaku Co Ltd.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4516.T
Recent news on Nippon Shinyaku
See all newsTable: Nippon Shinyaku -Q1 group results (IFRS)
Brief: Elixirgen Therapeutics And Nippon Shinyaku Enter Into An Option Agreement For The Development And Commercialization Of Exg-7001 For Duchenne Muscular Dystrophy
Table: Nippon Shinyaku -2025/26 group results (IFRS)
Table: Nippon Shinyaku -2025/26 parent results
Table: Nippon Shinyaku -9-MTH group results (IFRS)